RAC - Charts & Price Action, page-4742

Looks like some games might be played today. Have a seller at $3.54 for 90 shares.

While a lot of people think the FTO announcement is a lot of nothing, I think it shows progress and there will be other smart money watching closely for an entry. I'm excited to hear about the breast cancer trial review which should get plenty of people interested. IMO most investors are not aware of the link of FTO with cancer and therefore it goes over the top of their heads, if you can directly say bisantrene kills xxx cancer, then it's a lot more clear cut...

Anyways, exciting times to see what bisantrene is capable of.